These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

535 related items for PubMed ID: 7504085

  • 1. Plasma 5-hydroxyindoleacetic acid as an indicator of monoamine oxidase-A inhibition in rat brain and peripheral tissues.
    Celada P, Artigas F.
    J Neurochem; 1993 Dec; 61(6):2191-8. PubMed ID: 7504085
    [Abstract] [Full Text] [Related]

  • 2. Monoamine oxidase inhibitors increase preferentially extracellular 5-hydroxytryptamine in the midbrain raphe nuclei. A brain microdialysis study in the awake rat.
    Celada P, Artigas F.
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Jun; 347(6):583-90. PubMed ID: 7689703
    [Abstract] [Full Text] [Related]

  • 3. Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.
    Riederer P, Youdim MB.
    J Neurochem; 1986 May; 46(5):1359-65. PubMed ID: 2420928
    [Abstract] [Full Text] [Related]

  • 4. GABA-elevating effects of the antidepressant/antipanic drug phenelzine in brain: effects of pretreatment with tranylcypromine, (-)-deprenyl and clorgyline.
    Todd KG, Baker GB.
    J Affect Disord; 1995 Dec 13; 35(3):125-9. PubMed ID: 8749840
    [Abstract] [Full Text] [Related]

  • 5. Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan.
    Sleight AJ, Marsden CA, Martin KF, Palfreyman MG.
    Br J Pharmacol; 1988 Feb 13; 93(2):303-10. PubMed ID: 2451963
    [Abstract] [Full Text] [Related]

  • 6. The effect of selective type A or type B monoamine oxidase inhibition on the intrasynaptosomal deamination of (3H)serotonin in rat spinal cord tissue.
    Azzaro AJ, Amedro JB, Brown LM, Smith DJ, Williams GM.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Jul 13; 338(1):9-13. PubMed ID: 2467212
    [Abstract] [Full Text] [Related]

  • 7. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
    Kato T, Dong B, Ishii K, Kinemuchi H.
    J Neurochem; 1986 Apr 13; 46(4):1277-82. PubMed ID: 2419508
    [Abstract] [Full Text] [Related]

  • 8. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
    Lenzen S, Nahrstedt H, Panten U.
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov 13; 324(3):190-5. PubMed ID: 6419132
    [Abstract] [Full Text] [Related]

  • 9. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
    Hewton R, Salem A, Irvine RJ.
    Clin Exp Pharmacol Physiol; 2007 Oct 13; 34(10):1051-7. PubMed ID: 17714093
    [Abstract] [Full Text] [Related]

  • 10. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I, Youdim MB, Finberg JP.
    J Neurochem; 1996 Oct 13; 67(4):1532-9. PubMed ID: 8858937
    [Abstract] [Full Text] [Related]

  • 11. Thyroid iodide transport is reduced by administration of monoamine oxidase A inhibitors to rats.
    Cabanillas AM, Masini-Repiso AM, Costamagna ME, Pellizas C, Coleoni AH.
    J Endocrinol; 1994 Nov 13; 143(2):303-8. PubMed ID: 7829993
    [Abstract] [Full Text] [Related]

  • 12. Serotonin and 5-hydroxyindoleacetic acid in plasma. Potential use as peripheral measures of MAO-A activity.
    Celada P, Sarrias MJ, Artigas F.
    J Neural Transm Suppl; 1990 Nov 13; 32():149-54. PubMed ID: 1708403
    [Abstract] [Full Text] [Related]

  • 13. Influence of monoamine oxidase inhibitors on striatonigral dynorphin system: a study with deprenyl and clorgyline.
    Sivam SP.
    Neuropeptides; 1993 Jul 13; 25(1):35-45. PubMed ID: 7692341
    [Abstract] [Full Text] [Related]

  • 14. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.
    Kan JP, Steinberg R, Mouget-Goniot C, Worms P, Bizière K.
    J Pharmacol Exp Ther; 1987 Jan 13; 240(1):251-8. PubMed ID: 3100771
    [Abstract] [Full Text] [Related]

  • 15. Effects of monoamine oxidase inhibition by clorgyline, deprenil or tranylcypromine on 5-hydroxytryptamine concentrations in rat brain and hyperactivity following subsequent tryptophan administration.
    Green AR, Youdim MB.
    Br J Pharmacol; 1975 Nov 13; 55(3):415-22. PubMed ID: 1203627
    [Abstract] [Full Text] [Related]

  • 16. Serotonergic measures in blood and brain and their correlations in rats treated with tranylcypromine, a monoamine oxidase inhibitor.
    Malyszko J, Urano T, Serizawa K, Yan D, Kozima Y, Takada Y, Takada A.
    Jpn J Physiol; 1993 Nov 13; 43(5):613-26. PubMed ID: 7511710
    [Abstract] [Full Text] [Related]

  • 17. The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimoxatone.
    Fowler CJ, Benedetti MS.
    J Neurochem; 1983 Jun 13; 40(6):1534-41. PubMed ID: 6406646
    [Abstract] [Full Text] [Related]

  • 18. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS.
    Biokhimiia; 1979 Feb 13; 44(2):195-207. PubMed ID: 435561
    [Abstract] [Full Text] [Related]

  • 19. In vivo evidence for the reversible action of the monoamine oxidase inhibitor brofaromine on 5-hydroxytryptamine release in rat brain.
    Bel N, Artigas F.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 May 13; 351(5):475-82. PubMed ID: 7543977
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.